<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03225690</url>
  </required_header>
  <id_info>
    <org_study_id>Hyperalgesia</org_study_id>
    <nct_id>NCT03225690</nct_id>
  </id_info>
  <brief_title>Prevention of Hyperalgesia With Epidural Morphine</brief_title>
  <official_title>Does Preemptive Epidural Morphine Prevent Remifentanil Induced Hyperalgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cukurova University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cukurova University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      American Society of Anaesthesiologist physical status (ASA) I-III 105 patients who undergoing
      major abdominal surgery in obstetric and gynaecology clinic were recruited to this study.
      Patients were randomized into the 3 groups. Lumbar epidural catheter will be inserted to the
      all patients. After than anaesthesia induction will provide with 2 mg/kg propofol and 0.6
      mg/kg rocuronium. Desflurane and azot protoxit (N2O)-O2 will use for anaesthesia maintenance.
      During surgical operation, 0.3 microgram/kg/h remifentanil infusion will continuous till the
      end of surgery. In group I, 2 ml serum physiologic (0.9 NaCL)will apply from epidural
      catheter before surgical incision. In group II, 1 mg morphine will apply from epidural
      catheter before surgical incision. In group III, 1 mg morphine will apply from epidural
      catheter at the time point of peritoneum is closed. Epidural patient controlled analgesia
      will provide with bupivacaine for postoperative analgesia. Postoperative pain will be
      assessed with numerical pain scale. Postoperative analgesic requirement will be calculated.
      Hyperalgesia will detect with algometer and von Frey ligaments.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This randomized, double blind, controlled study will perform after obtaining informed consent
      and ethics approval. American Society of Anaesthesiologist physical status (ASA) I-III 105
      patients who undergoing major abdominal surgery in obstetric and gynaecology clinic were
      recruited to this study. Patients were randomized into the 3 groups with computerized
      randomization programme. Lumbar epidural catheter will be inserted to the all patients. After
      than anaesthesia induction will provide with 2 mg/kg propofol and 0.6 mg/kg rocuronium.
      Desflurane and N2O-O2 will use for anaesthesia maintenance. During surgical operation, 0.3
      microgram/kg/h remifentanil infusion will continuous till the end of surgery. In group I, 2
      ml serum physiologic (0.9 NaCL)will apply from epidural catheter before surgical incision. In
      group II, 1 mg morphine will apply from epidural catheter before surgical incision. In group
      III, 1 mg morphine will apply from epidural catheter at the time point of peritoneum is
      closed. Epidural patient controlled analgesia will provide with bupivacaine for postoperative
      analgesia. Postoperative pain will be assessed with numerical pain scale. Postoperative
      analgesic requirement will be calculated. Hyperalgesia will detect with algometer and von
      Frey ligaments.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 19, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative analgesic requirement</measure>
    <time_frame>Till the postoperative 24th hour.</time_frame>
    <description>Calculation of epidural bupivacain consumption</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Algometer values</measure>
    <time_frame>Till the postoperative 24th hour.</time_frame>
    <description>Postoperative pain will detect with algometer</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">105</enrollment>
  <condition>Hyperalgesia</condition>
  <arm_group>
    <arm_group_label>serum physiologic</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2 ml serum physiologic will apply via epidural catheter before surgical incision.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preemptive Morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 mg morphine will apply via epidural catheter before surgical incision.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 mg morphine will apply via epidural catheter before at the time point of the peritoneum closed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>Prevention of remifentanil induced hyperalgesia</description>
    <arm_group_label>Preemptive Morphine</arm_group_label>
    <arm_group_label>Morphine</arm_group_label>
    <other_name>Group I-II</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Serum physiologic</intervention_name>
    <description>For placebo, serum physiologic will use</description>
    <arm_group_label>serum physiologic</arm_group_label>
    <other_name>Group III</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-III patients

          -  Patients who undergoing major abdominal surgery

        Exclusion Criteria:

          -  ASA IV and up

          -  Coagulopathy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ebru Biricik</last_name>
    <role>Study Chair</role>
    <affiliation>Cukurova University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ebru Biricik</last_name>
    <phone>5052420223</phone>
    <email>ebrubiricik01@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Feride Karacaer</last_name>
    <phone>5062628416</phone>
    <email>feridekaracaer@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Çukurova University Balcalı Hospital</name>
      <address>
        <city>Adana</city>
        <zip>01380</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Çukurova University B Hospital</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2017</study_first_submitted>
  <study_first_submitted_qc>July 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2017</study_first_posted>
  <last_update_submitted>March 2, 2018</last_update_submitted>
  <last_update_submitted_qc>March 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cukurova University</investigator_affiliation>
    <investigator_full_name>ebru biricik</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperalgesia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

